# Insulin Glargine Versus Twice-Daily NPH

> **NCT00687453** · PHASE4 · TERMINATED · sponsor: **Charles Drew University of Medicine and Science** · enrollment: 27 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin glargine at bedtime instead of NPH
- **DRUG:** NPH twice-daily

## Key facts

- **NCT ID:** NCT00687453
- **Lead sponsor:** Charles Drew University of Medicine and Science
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-02
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2023-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687453, "Insulin Glargine Versus Twice-Daily NPH". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00687453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*